Marshall Islands vs New Caledonia: The number of people with susceptibility test result for rifampicin
Marshall Islands
100
in 2021
New Caledonia
100
in 2021
Marshall Islands rank
2nd
New Caledonia rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Marshall Islands
- New Caledonia
How they compare
Marshall Islands currently reports 100 against 100 in New Caledonia, a difference of 0.
Across all 5 years both countries report, New Caledonia has been ahead every year.
Marshall Islands ranks 2nd and New Caledonia ranks 2nd of 146 countries.
New Caledonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.97 | 100 | 3.03 | New Caledonia |
| 2020s | 87.04 | 100 | 12.96 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Marshall Islands or New Caledonia?
- Marshall Islands, at 100 against 100 in New Caledonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Marshall Islands and New Caledonia?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and New Caledonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Marshall Islands and New Caledonia rank globally for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 2nd and New Caledonia ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.